Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of antidiabetic drugs. It serves as a building block for DPP-4 inhibitors, which are important in the treatment of type 2 diabetes. The compound’s structure allows for selective binding and enhanced metabolic stability, making it valuable in optimizing drug efficacy and pharmacokinetics. It is also employed in the preparation of bioactive molecules where fluorinated aromatic groups contribute to improved potency and resistance to oxidative degradation.